OBSTETRICS & GYNECOLOGY CONNECT powered by COR2ED

Prof. Domenica Lorusso provides a concise, guideline-based overview of how molecular classification and clinical trial data inform treatment selection in advanced #endometrialcancer 📺 Watch the video View the slides: cor2ed.com/obstetrics-gyn… 🤝 Programme endorsed by @WarOnCancer Supported by an Independent Educational Grant from Eisai Europe Limited. Eisai Europe Limited has financially supported this activity and has had no influence on its creation or content #MedEd #obgyn

ESGO guidelines recommend ICI + chemotherapy followed by maintenance ICI ± PARPi for advanced/recurrent non-dMMR (pMMR) #endometrialcancer But what if chemotherapy is contraindicated? Get an update on the ESGO guidelines and how they translate to clinical practice 📺 Video from Prof. Domenica Lorusso View the slides: cor2ed.com/obstetrics-gyn… 🤝 Programme endorsed by @WarOnCancer Supported by an Independent Educational Grant from Eisai Europe Limited. Eisai Europe Limited has financially supported this activity and has had no influence on its creation or content #MedEd #obgyn #endometrialcancer

We are delighted to receive a programme endorsement from the Gynecologic Oncology Trial and Investigation Consortium (GOTIC) once again. Check out the programme ⬇️ Understanding HER2 testing in gynecological cancers: best practices and treatment implications >> cor2ed.com/precision-onco… We greatly appreciate and value the longstanding collaboration with GOTIC over the past 7 years! We look forward to many more to come 🤝 Programme supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only. #MedicalEducation #precisionmedicine 📷

Exploring best practice in HER2 testing in gynecological cancers What are the guidelines around HER2 IHC testing & scoring in endometrial, cervical & ovarian cancers? How does HER2 status impact treatment selection? Prof. Fernando Soares answers these questions in a guideline-based overview 📺 Video in this post 🔗 Slides >> cor2ed.com/precision-onco… Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only. #MedEd #obgyn #OncTwitter #precisiononcology

📺 Endometrial cancer update from Prof. Domenica Lorusso ✔️ Navigating recent ESGO guidelines ✔️ Implications for clinical practice View the slides: cor2ed.com/obstetrics-gyn… 🤝 Programme endorsed by @WarOnCancer Supported by an Independent Educational Grant from Eisai Europe Limited. Eisai Europe Limited has financially supported this activity and has had no influence on its creation or content #MedEd #obgyn #endometrialcancer

Understanding HER2 testing in gynecological cancers: Best practices and treatment implications - Get a guideline-driven overview of immunohistochemistry testing in endometrial, cervical & ovarian cancers - Find out why accurate assessment is now critical for treatment selection 📺 From Prof. Fernando Soares Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.

📣 New video! Understanding HER2 testing in gynecological cancers Prof. Fernando Soares provides a guideline-based overview 📺 View/download the slides for more details: cor2ed.com/precision-onco… Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only. #MedEd #obgyn #MedTwitter #precisionmedicine

➡️ HER2 IHC testing is recommended in p53-aberrant endometrial carcinoma ➡️ It may be considered in selected advanced/recurrent cervical & ovarian cancers when evaluating eligibility for HER2-targeted therapies 🧬 Find out more about #HER2 testing in gynecological cancers, best practice, & treatment selection 📺 From Prof. Fernando Soares Get the slides for more: cor2ed.com/precision-onco… Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only. #MedEd #obgyn #MedTwitter #precisionmedicine

Optimising treatment selection in advanced #endometrialcancer Prof. Domenica Lorusso shares insights on how to navigate recent ESGO guidelines and the implications for clinical practice. 📺 Video in this post! View the slides: cor2ed.com/obstetrics-gyn… 🤝 Programme endorsed by @WarOnCancer Supported by an Independent Educational Grant from Eisai Europe Limited. Eisai Europe Limited has financially supported this activity and has had no influence on its creation or content #MedEd #obgyn #endometrial

You can review the latest ESGO guidelines for advanced endometrial cancer in one clear, evidence based resource based resource: #GynecologicOncology #ESGO2026

Understanding HER2 testing in gynecological cancers: Best practices and treatment implications ✔️ Get a guideline-driven overview of immunohistochemistry testing in endometrial, cervical & ovarian cancers ✔️ Find out why accurate assessment is now critical for treatment selection 📺 From Prof. Fernando Soares Get the slides for more details: cor2ed.com/precision-onco… Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only. #MedEd #obgyn #MedTwitter

Breast Cancer Oncologists! Check out the new ADC & AEs Blueprint – a concise, evidence‑based guide that lets HPCs quickly master trastuzumab deruxtecan dosing, the 5‑step nausea protocol, plus the fatigue and “Five S” ILD workflow. Turn complex side‑effects into predictable, manageable care cor2ed.com/breast-cancer-… #Oncology #BreastCancer #HCPTools This educational programme is supported by an Independent Educational Grant from AstraZeneca

Breast Cancer Oncologists! Check out this new ADC & AEs Blueprint for a concise, evidence‑based guide that gives you a clear pathway to managing T-DXd–related adverse events in HER2+ mBC. Includes the 5‑step nausea protocol, plus the fatigue and “Five S” ILD workflow. Anticipate toxicities, prevent them where possible and intervene early. Download the paper now. #Oncology #BreastCancer #HCPTools

Optimising treatment selection in advanced endometrial cancer 📺 Expert video from Prof. Domenica Lorusso Explore ESGO guidelines & what they mean for clinical practice -Clinical relevance of molecular subtypes/their role in risk stratification & treatment planning -Tx algorithms for advanced/recurrent disease, inc. distinctions between dMMR/non-dMMR tumours -pembrolizumab + lenvatinib as a chemotherapy-free option for selected pts -Established systemic treatment strategies across molecular subgroups View the slides: cor2ed.com/obstetrics-gyn… 🤝 Programme endorsed by @WarOnCancer Supported by an Independent Educational Grant from Eisai Europe Limited. Eisai Europe Limited has financially supported this activity and has had no influence on its creation or content #MedEd #obgyn #OncTwitter

Prof. Domenica Lorusso provides a concise, guideline-based overview of how molecular classification and clinical trial data inform treatment selection in advanced #endometrialcancer 📺 Watch the video View the slides: cor2ed.com/obstetrics-gyn… 🤝 Programme endorsed by @WarOnCancer Supported by an Independent Educational Grant from Eisai Europe Limited. Eisai Europe Limited has financially supported this activity and has had no influence on its creation or content #MedEd #obgyn #endometrialcancer

ESGO guidelines recommend ICI + chemotherapy followed by maintenance ICI ± PARPi for advanced/recurrent non-dMMR (pMMR) #endometrialcancer But what if chemotherapy is contraindicated? Get an update on the ESGO guidelines and how they translate to clinical practice 📺 Video from Prof. Domenica Lorusso View the slides: cor2ed.com/obstetrics-gyn… 🤝 Programme endorsed by @WarOnCancer Supported by an Independent Educational Grant from Eisai Europe Limited. Eisai Europe Limited has financially supported this activity and has had no influence on its creation or content. #MedEd #obgyn #endometrialcancer

📺 Endometrial cancer update from Prof. Domenica Lorusso ✔️ Navigating recent ESGO guidelines ✔️ Implications for clinical practice View the slides: cor2ed.com/obstetrics-gyn… 🤝 Programme endorsed by @WarOnCancer Supported by an Independent Educational Grant from Eisai Europe Limited. Eisai Europe Limited has financially supported this activity and has had no influence on its creation or content #MedEd #obgyn #endometrialcancer

Optimising treatment selection in advanced endometrial cancer Prof. Domenica Lorusso shares insights on how to navigate recent ESGO-guidelines and the implications for clinical practice. 📺 Video in this post! Programme endorsed by @WarOnCancer Supported by an Independent Educational Grant from Eisai Europe Limited. Eisai Europe Limited has financially supported this activity and has had no influence on its creation or content

Optimising treatment selection in advanced #endometrialcancer Prof. Domenica Lorusso shares insights on how to navigate recent ESGO-guidelines and the implications for clinical practice. 📺 Video in this post! View the slides: cor2ed.com/obstetrics-gyn… 🤝 Programme endorsed by @WarOnCancer Supported by an Independent Educational Grant from Eisai Europe Limited. Eisai Europe Limited has financially supported this activity and has had no influence on its creation or content #MedEd #obgyn #endometrial

We are proud to share that more than 50,000 HCPs around the world follow @COR2EDMedEd's programmes to stay up to date with the latest science, and provide their patients with the best possible care 🎉 ~ OBSTETRICS & GYNECOLOGY CONNECT is an initiative of COR2ED ~ 👏 Over 25k HCPs subscribe to the COR2ED YouTube channel to see educational videos as soon as they're released 👏 More than 25k followers stay up to date with #MedEd on the COR2ED social media channels on X, LinkedIn, Instagram, and BlueSky Are you part of our community yet? 🎓 Follow us for engaging videos, podcasts, publications, micro learnings, and more! Our programmes are developed by renowned medical experts and endorsed by Medical Societies & Patient Advocacy Groups ✅ Come and follow us on YouTube! @cor2edtheheartofmedicaledu700" target="_blank" rel="nofollow noopener">youtube.com/@cor2edthehear… #medicaleducation #MedTwitter